BRIACELL THERAP (BCTX) has been upgraded to a Zacks Rank #1 (Strong Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

It doesn't matter if you're a growth, value, income, or momentum-focused investor -- building a successful investment portfolio takes skill, research, and a little bit of luck. But how do you find the ...

Whether you're a growth, value, income, or momentum-focused investor, building a successful investment portfolio takes skill, research, and a little bit of luck. But what's the best way to find the ...

According to the average brokerage recommendation (ABR), one should invest in Alaska Air (ALK). It is debatable whether this ...

One stock that might be an intriguing choice for investors right now is The Progressive Corporation (PGR Quick QuotePGR - ...

Steelcase (SCS) is a stock many investors are watching right now. SCS is currently sporting a Zacks Rank of #2 (Buy), as well as an A grade for Value.

Value investors will likely look at more than just these metrics, but the above data helps show that Sanofi is likely undervalued currently. And when considering the strength of its earnings outlook, ...

So far this year, the Nasdaq soared more than 18%, whereas one of its listed stocks, electric vehicle (EV) manufacturer NIO ...

EZCORP, American Superconductor, Byrna Technologies, Lifeway Foods and Willdan are part of the Zacks Analyst Blog.

Zacks Dividend Fund earns a Below Average Process Pillar rating. The process benefits from the experience of the management team, which averages 30 years at this fund. However, the rating is held ...